GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » 3-Year EPS without NRI Growth Rate

Kyowa Kirin Co (TSE:4151) 3-Year EPS without NRI Growth Rate : 12.60% (As of Sep. 2023)


View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co 3-Year EPS without NRI Growth Rate?

Kyowa Kirin Co's EPS without NRI for the three months ended in Sep. 2023 was 円59.35.

During the past 12 months, Kyowa Kirin Co's average EPS without NRI Growth Rate was -15.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 4.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Kyowa Kirin Co was 671.50% per year. The lowest was -84.60% per year. And the median was 4.90% per year.


Competitive Comparison of Kyowa Kirin Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's 3-Year EPS without NRI Growth Rate falls into.



Kyowa Kirin Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Kyowa Kirin Co  (TSE:4151) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Kyowa Kirin Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (TSE:4151) Business Description

Industry
Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines